Banque Transatlantique SA Buys 107,578 Shares of Keurig Dr Pepper, Inc $KDP

Key Points

• Banque Transatlantique SA significantly increased its position in Keurig Dr Pepper, raising its holdings by 1,108.5% to own 117,283 shares worth approximately $3.7 million.
• Other institutional investors, such as Vanguard Group and JPMorgan Chase & Co., also expanded their stakes, further highlighting rising institutional interest in Keurig Dr Pepper.
• Keurig Dr Pepper reported a quarterly revenue of $4.16 billion, exceeding analyst estimates, while earnings per share matched expectations at $0.49.

Banque Transatlantique SA increased its holdings in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 1,108.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 117,283 shares of the company's stock after purchasing an additional 107,578 shares during the period. Banque Transatlantique SA's holdings in Keurig Dr Pepper were worth $3,709,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the business. ST Germain D J Co. Inc. bought a new position in Keurig Dr Pepper during the 1st quarter worth about $27,000. WPG Advisers LLC bought a new position in Keurig Dr Pepper during the 1st quarter worth about $43,000. Continuum Advisory LLC lifted its stake in Keurig Dr Pepper by 82.5% in the 1st quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock valued at $46,000 after acquiring an additional 602 shares in the last quarter. Global Trust Asset Management LLC bought a new stake in Keurig Dr Pepper in the 1st quarter valued at approximately $48,000. Finally, LRI Investments LLC lifted its stake in Keurig Dr Pepper by 65.6% in the 4th quarter. LRI Investments LLC now owns 1,527 shares of the company's stock valued at $49,000 after acquiring an additional 605 shares in the last quarter. Institutional investors own 93.99% of the company's stock.

Keurig Dr Pepper Stock Performance

KDP stock traded down $0.60 during midday trading on Friday, reaching $28.65. 21,094,736 shares of the company were exchanged, compared to its average volume of 18,428,686. Keurig Dr Pepper, Inc has a one year low of $28.58 and a one year high of $38.28. The firm has a market capitalization of $38.92 billion, a price-to-earnings ratio of 25.58, a price-to-earnings-growth ratio of 1.57 and a beta of 0.47. The business has a 50-day moving average price of $32.94 and a two-hundred day moving average price of $33.49. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.64 and a quick ratio of 0.40.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The company reported $0.49 EPS for the quarter, meeting the consensus estimate of $0.49. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The firm had revenue of $4.16 billion for the quarter, compared to the consensus estimate of $4.14 billion. During the same period in the previous year, the company earned $0.45 earnings per share. The company's quarterly revenue was up 6.1% on a year-over-year basis. Equities research analysts forecast that Keurig Dr Pepper, Inc will post 1.92 EPS for the current year.

Insider Buying and Selling at Keurig Dr Pepper

In other Keurig Dr Pepper news, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the transaction, the insider directly owned 82,511 shares of the company's stock, valued at $2,777,320.26. This represents a 12.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Robert James Gamgort sold 208,000 shares of the company's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $32.90, for a total value of $6,843,200.00. Following the completion of the transaction, the director directly owned 2,292,169 shares in the company, valued at approximately $75,412,360.10. This represents a 8.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 459,601 shares of company stock worth $15,228,872. Corporate insiders own 0.40% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. UBS Group cut their target price on Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating on the stock in a research note on Wednesday, August 27th. Hsbc Global Res cut Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 26th. HSBC restated a "hold" rating and issued a $30.00 target price (down previously from $42.00) on shares of Keurig Dr Pepper in a research note on Tuesday, August 26th. Barclays boosted their target price on Keurig Dr Pepper from $37.00 to $39.00 and gave the company an "overweight" rating in a research note on Monday, July 28th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating on the stock in a research note on Tuesday, August 26th. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $38.38.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.